Cargando…

Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation

Background: Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease and patients are under an increased risk for cardiovascular (CV) events and mortality. The increased CV risk for patients with SLE seems to be caused by a premature and accelerated atherosclerosis, attributab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marczynski, Paul, Meineck, Myriam, Xia, Ning, Li, Huige, Kraus, Daniel, Roth, Wilfried, Möckel, Tamara, Boedecker, Simone, Schwarting, Andreas, Weinmann-Menke, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956579/ https://www.ncbi.nlm.nih.gov/pubmed/33669022 http://dx.doi.org/10.3390/ijms22052291

Ejemplares similares

Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus
por: Engel, Sinah, et al.
Publicado: (2021)

Validation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in an academic tertiary care centre
por: Schmidtmann, Irene, et al.
Publicado: (2023)

Twelve-Week Internet-Based Individualized Exercise Program in Adults With Systemic Lupus Erythematosus: Protocol for a Randomized Controlled Trial
por: Boedecker, Simone Cosima, et al.
Publicado: (2020)

Six-Month Follow-Up after Vaccination with BNT162b2: SARS-CoV-2 Antigen-Specific Cellular and Humoral Immune Responses in Hemodialysis Patients and Kidney Transplant Recipients
por: Boedecker-Lips, Simone Cosima, et al.
Publicado: (2022)

Plasma exchange for treatment of a therapy‐related thrombotic microangiopathy in a patient with advanced hepatocellular carcinoma—A case report
por: Stortz, Marco, et al.
Publicado: (2023)

The macrocyclic lactone oxacyclododecindione reduces fibrosis progression
por: Saurin, Sabrina, et al.
Publicado: (2023)

COVID-19—Importance for Patients on the Waiting List and after Kidney Transplantation—A Single Center Evaluation in 2020–2021
por: Boedecker, Simone C., et al.
Publicado: (2021)

Transcriptome analysis of renal ischemia/reperfusion (I/R) injury in BAFF and BAFF-R deficient mice
por: Möckel, Tamara, et al.
Publicado: (2023)

Knockout of the KH-Type Splicing Regulatory Protein Drives Glomerulonephritis in MRL-Fas(lpr) Mice
por: Schmidtke, Lisa, et al.
Publicado: (2021)

The role of perivascular adipose tissue in obesity‐induced vascular dysfunction
por: Xia, Ning, et al.
Publicado: (2016)

Drug Candidates for Autoimmune Diseases
por: Saurin, Sabrina, et al.
Publicado: (2022)

The Involvement of Sirtuin 1 Dysfunction in High-Fat Diet-Induced Vascular Dysfunction in Mice
por: Xia, Ning, et al.
Publicado: (2022)

The Cellular and Humoral Immune Response to SARS-CoV-2 Messenger RNA Vaccines Is Significantly Better in Liver Transplant Patients Compared with Kidney Transplant Patients
por: Lautem, Anja, et al.
Publicado: (2023)

IL-17–producing follicular Th cells enhance plasma cell differentiation in lupus-prone mice
por: Kim, Vera, et al.
Publicado: (2022)

Ectonucleotidase-Mediated Suppression of Lupus Autoimmunity and Vascular Dysfunction
por: Knight, Jason S., et al.
Publicado: (2018)

Mouse models, antibodies, and neuroimaging: Current knowledge and future perspectives in neuropsychiatric systemic lupus erythematosus (NPSLE)
por: Tomalla, Vanessa, et al.
Publicado: (2023)

Validating quantitative PCR assays for cfDNA detection without DNA extraction in exercising SLE patients
por: Neuberger, Elmo W. I., et al.
Publicado: (2021)

NMDA Receptors in Health and Diseases: New Roles and Signaling Pathways—Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Autoantibodies as Potential Biomarkers of Fatigue in Patients with Rheumatic Diseases
por: Marinoska, Tatjana, et al.
Publicado: (2023)

Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus‐Prone Mice
por: Oaks, Zachary, et al.
Publicado: (2016)

Epigenetic Aspects of Systemic Lupus Erythematosus
por: Relle, Manfred, et al.
Publicado: (2015)

Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients
por: Daamen, Andrea R., et al.
Publicado: (2023)

Perivascular adipose tissue promotes vascular dysfunction in murine lupus
por: Shi, Hong, et al.
Publicado: (2023)

T Follicular Helper Cells Mediate Expansion of Regulatory B Cells via IL-21 in Lupus-Prone MRL/lpr Mice
por: Yang, Xue, et al.
Publicado: (2013)

Impact of concomitant medication use on belimumab efficacy and safety in patients with systemic lupus erythematosus
por: Schwarting, A, et al.
Publicado: (2016)

T Cell-Derived IL-17A Induces Vascular Dysfunction via Perivascular Fibrosis Formation and Dysregulation of (·)NO/cGMP Signaling
por: Schüler, Rebecca, et al.
Publicado: (2019)

Role of MHC-Linked Susceptibility Genes in the Pathogenesis of Human and Murine Lupus
por: Relle, Manfred, et al.
Publicado: (2012)

Reduced receptor editing in lupus-prone MRL/lpr mice
por: Lamoureux, Jennifer L., et al.
Publicado: (2007)

Mesangial cells of lupus-prone mice are sensitive to chemokine production
por: Ka, Shuk-Man, et al.
Publicado: (2007)

The effect of esculentoside A on lupus nephritis-prone BXSB mice
por: Ma, Hualin, et al.
Publicado: (2012)

Phenotypic and functional alterations of pDCs in lupus-prone mice
por: Zhou, Zhenyuan, et al.
Publicado: (2016)

Death receptor 6 contributes to autoimmunity in lupus-prone mice
por: Fujikura, Daisuke, et al.
Publicado: (2017)

Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice
por: Zeng, Jing, et al.
Publicado: (2019)

Phenotypic and functional alterations of peritoneal macrophages in lupus-prone mice
por: Tejon, Gabriela, et al.
Publicado: (2022)

Correction: T Follicular Helper Cells Mediate Expansion of Regulatory B Cells via IL-21 in Lupus-Prone MRL/lpr Mice
por: Yang, Xue, et al.
Publicado: (2013)

The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
por: Shi, Yu, et al.
Publicado: (2019)

Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
por: Basta, Fabio, et al.
Publicado: (2020)

Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice.
por: Pollard, K M, et al.
Publicado: (2001)

Effects of Cystamine on antioxidant activities and regulatory T cells in lupus-prone mice
por: Hsu, Tsai-Ching, et al.
Publicado: (2013)

CD38 Correlates with an Immunosuppressive Treg Phenotype in Lupus-Prone Mice
por: Pérez-Lara, Jocelyn C., et al.
Publicado: (2021)

CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice
por: Huang, Michelle W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_feis4ordr2dlc2b2j77vab9sb6